A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT01824290 · COMPLETED
Trial details
- NCT number
- NCT01824290
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-05
- Primary completion
- 2019-03-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.